Astellas Pharma Inc (ALPMY)
10.70
0.00 (0.00%)
USD |
OTCM |
Nov 15, 16:00
Astellas Pharma Total Assets (Quarterly): 23.58B for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 24.24B |
| March 31, 2024 | 23.58B |
| December 31, 2023 | 23.89B |
| September 30, 2023 | 23.72B |
| June 30, 2023 | 19.32B |
| March 31, 2023 | 18.44B |
| December 31, 2022 | 19.17B |
| September 30, 2022 | 17.88B |
| June 30, 2022 | 18.17B |
| March 31, 2022 | 19.11B |
| December 31, 2021 | 20.48B |
| September 30, 2021 | 20.20B |
| June 30, 2021 | 20.35B |
| March 31, 2021 | 20.61B |
| December 31, 2020 | 22.27B |
| September 30, 2020 | 21.17B |
| June 30, 2020 | 20.97B |
| March 31, 2020 | 21.42B |
| December 31, 2019 | 18.27B |
| September 30, 2019 | 18.34B |
| June 30, 2019 | 17.86B |
| March 31, 2019 | 17.11B |
| December 31, 2018 | 17.47B |
| September 30, 2018 | 16.60B |
| June 30, 2018 | 16.89B |
| Date | Value |
|---|---|
| March 31, 2018 | 17.49B |
| December 31, 2017 | 17.15B |
| September 30, 2017 | 16.85B |
| June 30, 2017 | 16.97B |
| March 31, 2017 | 16.23B |
| December 31, 2016 | 15.94B |
| September 30, 2016 | 16.92B |
| June 30, 2016 | 16.47B |
| March 31, 2016 | 16.01B |
| December 31, 2015 | 14.84B |
| September 30, 2015 | 14.77B |
| June 30, 2015 | 14.51B |
| March 31, 2015 | 14.94B |
| December 31, 2014 | 15.50B |
| September 30, 2014 | 15.68B |
| June 30, 2014 | 15.94B |
| March 31, 2014 | 16.06B |
| December 31, 2013 | 14.92B |
| September 30, 2013 | 15.30B |
| June 30, 2013 | 14.94B |
| March 31, 2013 | 16.62B |
| December 31, 2012 | 16.49B |
| September 30, 2012 | 17.00B |
| June 30, 2012 | 16.84B |
| March 31, 2012 | 18.36B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
17.88B
Minimum
Sep 2022
24.24B
Maximum
Sep 2024
20.70B
Average
20.48B
Median
Dec 2021
Total Assets (Quarterly) Benchmarks
| Pfizer Inc | 219.48B |
| Takeda Pharmaceutical Co Ltd | 102.04B |
| Nxera Pharma Co Ltd | 972.39M |
| PeptiDream Inc | 595.81M |
| Healios KK | 110.68M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 13.04B |
| Shareholders Equity (Quarterly) | 10.54B |
| Debt to Equity Ratio | 0.5765 |
| Current Ratio | 0.9292 |
| Net Debt Paydown Yield | 1.06% |